Successful full-dose DeVIC therapy in a patient with advanced-stage extranodal natural killer/T-cell lymphoma refractory to L-asparaginase.

Junko WatanabeShinichi MakitaYuta ItoShunsuke HattaTomotaka SuzukiSayako YudaAkiko Miyagi MaeshimaSuguru FukuharaWataru MunakataTatsuya SuzukiDai MaruyamaSung-Won KimKoji Izutsu

Published in: Annals of hematology (2018)

Keyphrases

case report
bone marrow
mesenchymal stem cells
replacement therapy